MedinCell S.A.

€28.44As of Sun 8 Nov 2026, 12:00 UTC
EPA:MEDCLHealthcare
Country France
PE (Fwd) •••
TSR 8Y CAGR 19.10%
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.91
PE TTM —
TSR TTM (26.05%)
Mkt cap €1.021B
ROIC (20.59%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€31
10.25%
(79.85%)
Buy 11|9|7|0|1
3Q26
4Q26
1Q27
2Q27
Earnings per share€
0.37
0.39
0.41
0.43
27.85%
28.73%
31.25%
29.43%
Revenue€M
61.03
61.31
62.69
62.14
2.34%
5.64%
8.12%
4.74%
Peers (US$1.147B)
Cap (US$)
PE
1.540B
—
902.0M
—
Capital
TTM
5Y
10Y
Leveragex
2.737
0.063
0.052
EBIT/Intx
0.749
3.107
2.939
Own earn%
(40.56)
55.90
61.17
Sh yield%
14.41
56.35
56.29
Owners
Insiders/Inst%
0.77
41.86
Short interest%
5.60
SBC / revenue%
0.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
5–9
$1 testx
−0.2
Incr. ROIC%
3